Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ LIMK1 Monoclonal Antibody (175CT3.2.5)
Mouse Monoclonal Antibody
Supplier: Invitrogen™ MA537486
Description
LIMK1 Monoclonal Antibody for Western Blot
LIMK1 is a serine/threonine kinase involved in regulation of actin cytoskeletal changes via phosphorylation of cofilin. LIMK1 has also been implicated in brain development. LIM domains are highly conserved cysteine-rich structures containing 2 zinc fingers. Although zinc fingers usually function by binding to DNA or RNA, the LIM motif probably mediates protein-protein interactions. LIM kinase-1 and LIM kinase-2 belong to a small subfamily with a unique combination of 2 N-terminal LIM motifs and a C-terminal protein kinase domain. LIMK1 is likely to be a component of an intracellular signaling pathway and may be involved in brain development. LIMK1 hemizygosity is implicated in the impaired visuospatial constructive cognition of Williams syndrome.
Specifications
LIMK1 | |
Monoclonal | |
Unconjugated | |
LIMK1 | |
EC 2.7.11.1; kinase LIMK1; KIZ-1; LIM domain kinase 1; lim kinase 1; LIM motif-containing protein kinase; LIM motif-containing protein kinase 1; LIM-domain containing protein kinase 1; LIM-domain containing, protein kinase; LIM-domain containing, protein kinase 1; Limk; LIMK1; LIMK-1 | |
Mouse | |
Ammonium sulfate precipitation | |
RUO | |
16885, 3984 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Western Blot | |
175CT3.2.5 | |
PBS with 0.09% sodium azide; pH 7.4 | |
P53667, P53668 | |
LIMK1 | |
KLH conjugated synthetic peptide between 479-508 amino acids from the C-terminal region of human LIMK1. | |
400 μL | |
Primary | |
Human, Mouse | |
Antibody | |
IgM κ |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction